Combatting platinum resistance in ovarian cancer
Ovarian cancer is the deadliest gynaecologic cancer and the fifth-leading cause of cancer-related deaths among women (1, 2). Commonly known as “The Whispering Disease” (3, 4), the symptoms of ovarian cancer are often difficult to detect in its early stages; symptoms can be very subtle, completely absent or misinterpreted as other benign conditions (5).